Formulation and optimization of sustained release tablets of venlafaxine resinates using response surface methodology

Indian Journal of Pharmaceutical Sciences

Volumn 71, Issue 4, 2009, Pages 387-394

  Madgulkar, Ashwini ^a   Bhalekar, M R ^a   Kolhe, V J ^a   Kenjale, Y D ^a  

^a AISSMS COLLEGE OF PHARMACY   (India)

Author keywords

Factorial design; Ion exchange resin; Matrix; Optimization; Response surface methodology; Sustained release; Venlafaxine hydrochloride

Indexed keywords

ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; INDION 244; ION EXCHANGE RESIN; POLYMER; UNCLASSIFIED DRUG; VENLAFAXINE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; FACTORIAL DESIGN; HYDROPHILICITY; HYDROPHOBICITY; PH; RESPONSE SURFACE METHOD; SUSTAINED DRUG RELEASE; TABLET FORMULATION; VALIDITY;

EID: 71049135698     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.57287     Document Type: Article

References (20)

1. Holliday SM, Benfield P. Venlafaxine: A review of its pharmacology and therapeutic potential in depression drugs. Drugs 1995;49:280-294
2. Haskins JT, Moyer JA, Muth EA, Sigg EB. Inhibition of noradrenergic neuronal activity by the novel bicyclic compounds, Wy-45,030 and Wy-45,881. Soc Neurosci Abstr 1984;10:262.
3. Muth EA, Moyer JA, Haskins JT, Andree TH, Husbands GEM, Biochemical, neurophysiological and behavioural effects of Wy-45,233, its enantiomers and other identified metabolites of the antidepressant venlafaxine. Drug Dev Res 1991;23:191-199
4. Cusack B, Nelson A, Richelson E. Binding of antidepressants to human brain receptors: focus on newer generation Compounds. Psychopharmacology 1994;114:559-565
5. Muth EA, Haskins JT, Moyer JA, Husbands GE. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ether cyclohexanol derivative. Biochem Pharmacol 1986;35:4493-4497
6. Troy SM, Parker VD, Fruncillo RJ, Chiang ST. The pharmacokinetics of venlafaxine when given in a twice-daily regimen. J Clin Pharmacol 1995;35:404-409
7. Conte U, Maggi L, Colombo P, La Manna A. Multi-layered hydrophilic matrices as constant release device (geomatrix systems). J Control Release 1993;26:39-47.
8. Dave BS, Amin AF, Patel MM. Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS PharmSciTech 2004;5:E34.
9. Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic design of experiments Part I: Fundamental aspects. Crit Rev Ther Drug Carrier Syst 2005;22:27-105.
10. Singh B, Ahuja N. Book review on Pharmaceutical Experimental Design. Int J Pharm 2000;195:247-248
11. Singh B, Dahiya M, Saharan V, Ahuja N. Optimizing drug delivery systems using systematic design of experiments: Part II: Retrospect and prospects. Crit Rev Ther Drug Carrier Syst 2005;22:215-293
12. Singh B, Mehta G, Kumar R, Bhatia A, Ahuja N, Katare OP. Design, development and optimization of nimesulide-loaded liposomal systems for topical application. Curr Drug Deliv 2005;2:143-153
13. Borodkin S. Ion exchange resins and sustained release. In: Swarbric J, Boylan J, editors. Encyclopedia of Pharmaceutical Technology. Vol.8. New York: Marcel Dekker Inc; 1992. p. 211.
14. Singh B, Ahuja N. Response surface optimization of drug delivery system. In: Jain NK, editor. Progress in controlled and novel drug delivery systems. 1st ed. New Delhi: CBS Publishers and Distributors; 2004. p. 470-479
15. Singh B, Singh S. A comprehensive computer program for the study of drug release kinetics from compressed matrices. Indian J Pharm Sci 1998;60:358-362
16. Peppas NA, Sahlin JJ. A simple equation for the description of solute release: III: Coupling of diffusion and relaxation. Int J Pharm 1989; 57:169-172
17. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110-111
18. Singh B, Ahuja N. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: Optimization of bioadhesion, dissolution, and diffusion parameters. Drug Develop Ind Pharm 2002;28:431-442
19. Sriwongjanya M, Bodmeier R. Effect of ion exchange resin on the drug release from matrix tablets. Eur J Pharm Biopharm 1998;46:321-327
20. Reddy RK, Srinivas M, Reddy S. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS Pharm Sci Tech 2003;4:Article 61.